A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis
Authors
- Patrick A. Flume (ORCID: https://orcid.org/0000-0002-1560-6879)
- Michael W. Konstan (ORCID: https://orcid.org/0000-0002-0557-7277)
- James Tolle (ORCID: https://orcid.org/0000-0003-1946-211X)
- Helen Usansky
- Jimmy Flarakos
- Jessica Basso
- Emily DiMango (ORCID: https://orcid.org/0000-0002-7849-6240)
- Sherry Li
- Ariel Teper
- Christina N. Ramirez
- Marcela Vergara
Institutions
- Medical University of South Carolina (US)
- Columbia University Irving Medical Center (US)
- Insmed (United States) (US)
- University School (US)
- Case Western Reserve University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Clinical Pharmacokinetics
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1007/s40262-025-01550-z
- Citations
- 5
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 7.59
Funders
- Insmed